PMID: 25782292Mar 19, 2015Paper

Role of magnetic resonance imaging in the early diagnosis of cognitive impairments in patients with type 1 diabetes mellitus

Vestnik rentgenologii i radiologii
M V NovoselovaO S Tonkikh

Abstract

To assess the role of brain magnetic resonance imaging (MRI) in patients with type 1 diabetes mellitus (DMI) in relation to clinical, metabolic, and psychoneurological disorders. Fifty-eight patients aged 16 to 30 years with DM1 were examined; a control group consisted of 29 healthy young people matched by gender and age. Their examination involved clinical, metabolic, and psychological testing. The quality of life was assessed using the general Medical Outcomes Study Short Form (MOS SF-36) and the specific Audit-Dependent Quality of Life (AdDQoL). The Montreal Cognitive Assessment (MoCa test) was employed to screen for cognitive impairments. All the patients were advised by a neurologist. Brain MRI using a 1.0 T Siemens Magnetom scanner was carried out to evaluate structural changes in the central nervous system. The examination of the patients with DM1 revealed the signs of grey matter atrophy, enlarged Virchow-Robin spaces, white matter injury, which correlated with the presence of chronic hyperglycemia, cognitive impairments, and microvascular complications. Routine brain MRI is best carried out in patients with DMI and poor disease control to timely implement therapeutic-and-prophylactic measures for preventing cognitive i...Continue Reading

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
F Barkhof
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
Anna PichiecchioCarla Uggetti
Dementia and Geriatric Cognitive Disorders
Augustina M A BrandsUtrecht Diabetic Encephalopathy Study Group
© 2021 Meta ULC. All rights reserved